(Q42278396)

19 October 2017

Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras (English)

1 reference

19 October 2017

Edward P Rybicki

3

0 references

author name string

Catherine B Pineo

series ordinal

1

1 reference

PubMed ID

23924054

19 October 2017

Inga I Hitzeroth

series ordinal

2

1 reference

19 October 2017

7 August 2013

1 reference

Plant Biotechnology Journal

19 October 2017

1 reference

19 October 2017

11

1 reference

19 October 2017

8

1 reference

19 October 2017

964-975

1 reference

Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies

19 October 2017

1 reference

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

21 January 2018

1 reference

Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography

21 January 2018

1 reference

Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris

21 January 2018

1 reference

Production of human papillomavirus type 16 virus-like particles in transgenic plants

21 January 2018

1 reference

Arrangement of L2 within the papillomavirus capsid

21 January 2018

1 reference

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

21 January 2018

1 reference

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells

21 January 2018

1 reference

Expression in tobacco and purification of beak and feather disease virus capsid protein fused to elastin-like polypeptides

21 January 2018

1 reference

Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein

21 January 2018

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

Plant-based production of biopharmaceuticals

21 January 2018

1 reference

Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications

21 January 2018

1 reference

Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

21 January 2018

1 reference

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.

21 January 2018

1 reference

A protective and broadly cross-neutralizing epitope of human papillomavirus L2.

21 January 2018

1 reference

Human papillomavirus vaccines in plants

21 January 2018

1 reference

Human papillomavirus infection requires cell surface heparan sulfate

21 January 2018

1 reference

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

21 January 2018

1 reference

Papillomavirus infections and human genital cancer

21 January 2018

1 reference

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

21 January 2018

1 reference

A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.

21 January 2018

1 reference

Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies

21 January 2018

1 reference

One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae

21 January 2018

1 reference

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant

21 January 2018

1 reference

Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.

21 January 2018

1 reference

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

21 January 2018

1 reference

Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes

21 January 2018

1 reference

Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.

21 January 2018

1 reference

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.

21 January 2018

1 reference

Perspectives for preventive and therapeutic HPV vaccines

21 January 2018

1 reference

Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.

21 January 2018

1 reference

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

21 January 2018

1 reference

Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.

21 January 2018

1 reference

Development of human papillomavirus chimaeric L1/L2 candidate vaccines

21 January 2018

1 reference

Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus

21 January 2018

1 reference

Atomic model of the papillomavirus capsid

21 January 2018

1 reference

Mechanisms of human papillomavirus-induced oncogenesis.

21 January 2018

1 reference

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

21 January 2018

1 reference

Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres

21 January 2018

1 reference

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

21 January 2018

1 reference

Chapter 2: The burden of HPV-related cancers

21 January 2018

1 reference

High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector

21 January 2018

1 reference

Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA.

21 January 2018

1 reference

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles

21 January 2018

1 reference

Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin

21 January 2018

1 reference

Plant-produced vaccines: promise and reality

21 January 2018

1 reference

Plant-made vaccines for humans and animals.

21 January 2018

1 reference

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

21 January 2018

1 reference

Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity

21 January 2018

1 reference

Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines

21 January 2018

1 reference

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

21 January 2018

1 reference

Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops

21 January 2018

1 reference

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.

21 January 2018

1 reference

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus

21 January 2018

1 reference

The virus-chaperone connection

21 January 2018

1 reference

Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus

21 January 2018

1 reference

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response

21 January 2018

1 reference

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16

21 January 2018

1 reference

Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi

21 January 2018

1 reference

A deletion and point mutation study of the human papillomavirus type 16 major capsid gene

21 January 2018

1 reference

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

21 January 2018

1 reference

Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PBI.12089

1 reference

19 October 2017

1 reference

PubMed ID

23924054